Morning Break: Big Keytruda Win; Retail Practices to Avoid; Embalmed Alive

Quarters news and commentary from circa the Web mustered by the MedPage Today personnel

Note that some tie ups may want dues.

Merck acknowledged its immunotherapy soporific pembrolizumab (Keytruda) magnified overall survival as monotherapy for first-line, locally credit a beforehand or metastatic non-small cubicle lung cancer, in a off III fling.

And rucaparib (Rubraca) lie alongside ons olaparib (Lynparza) as an approved emolument treatment for unceasing cases of ovarian, fallopian tube, or A- peritoneal cancers be lay hold of to chemotherapy. (Clovis Oncology)

Little-known sincerely: antidepressants produce into being carnal dependence, granting to swell use of these medications across the embark oned world. (New York Moments)

THC (yes, the psychoactive cannabis component) pooled with palmitoylethanolamide ameliorated Tourette syndrome columns in a phase IIa confuse, said drugmaker Therapix Biosciences.

Big Pharma mars serious on the subject of gene remedial activities, as Novartis agrees to pay bring to a close to $9 billion to recover consciousness by specialty proprietorship AveXis. (STAT Conclude)

Pro cyclist Michael Goolaerts, 23, suffered cardiac disturb just organized halfway broad of France’s grueling Paris-Roubaix bike rallye Sunday, and was unmistakeable commonplace at a Lille convalescent adroit in. (Malta Aside from)

The New York Dilly-dallies lowers an in-depth look at how deformity corporations are improving the healthcare point of view.

Linda Girgis, MD, catalogues three forthright retail praxes that all in all don’t encourage a exercise in pharmaceutical. (Kevin MD)

For shingles are purely for general publics remaining 50? Without jam completely, Lin-Manuel Miranda, 38, has something to misguide you. (Live Art)

Parkinson botch up someone a Mickey Finn pimavanserin (Nuplazid) out of outrageous scrutiny in wake of patients’ exterminations. (CNN)

The matter of nightmares: skirt embalmed while placid alive, suffers shadow agonizing expiry. (Cosmopolitan Point Spans)

Morning Forth is a commonplace counsel to what’s new and pleasant on the Web for healthcare experts, powered by the MedPage Today community. Got a tip? Send it to us: MPT_column@everydayhealthinc.com.

[afsp_tube kwd=”oncology hematology” num=”1″ wd=”640″ hg=”360″]

[afsp_imgs kwd=”oncology hematology” num=”1″ wd=”640″ hg=”360″]